Update on Copper Silver Project | Company Announcement
Investegate announcements from Update on Copper Silver Project
Source: investegate.co.uk
📰 Exclusive Option News
Exclusive Option News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exclusive Option. Real-time updates on events, politics, business and more.
Biocytogen Pharmaceuticals Co., Ltd. Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma
Biocytogen Pharmaceuticals Co., Ltd. announced that it has entered into an Exclusive Option and License Agreement with Radiance Biopharma Inc. The agreement grants Radiance an option to license from...
Radiance Biopharma Inc Biocytogen Pharmaceuticals Beijing Co Ltd Biocytogen Pharmaceuticals Exclusive Option License Agreement Radiance Biopharma
Source: marketscreener.com
Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma
BEIJING & BOSTON, January 08, 2024--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today announces that it has entered into an Exclusive Option and License Agreement with Radiance Biopharma Inc. ("Radiance"), a biotechnology company specializing in developing next generation Antibody Drug Conjugates.
San Francisco United States Haimen Jiangsu Yuelei Shen Marc Lippman Alphageneron Pharmaceuticals Inc
Source: yahoo.com
Pyx Resources Limited (NSX:PYX) Operations Update Q1 2023
PYX Resources Ltd (LON:PYX) (NSX:PYX), the worlds second-largest publicly listed zircon producer by zircon resources, is pleased to provide an operational update for the three months ended 31 March 2023.
Source: abnnewswire.net
Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...
United Kingdom Matthew Deyoung Jason Baum Novarock Biotherapeutics Douglase Onsi Society For Immunotherapy Of Cancer
Source: prnewswire.com
Leap Therapeutics Provides Update on BeiGene Option Agreement for DKN-01
/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...
United Kingdom Matthew Deyoung Douglase Onsi Prnewswire Leap Therapeutics Inc Drug Administration Leap Therapeutics Inc
Source: prnewswire.com
Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide
Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide February 04, 2021 11:35 ET | Source: Alphageneron Pharmaceuticals Alphageneron Pharmaceuticals Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany,...
United States United Kingdom Technische Universit Multimmune Gmb Graham Pockley Alphageneron Pharmaceuticals
Source: globenewswire.com
Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For ... Alphageneron PharmaceuticalsFebruary 4, 2021 GMT CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1st, 2020, for its clinical stage autologous Natural Ki...
United States United Kingdom Technische Universit Multimmune Gmb Graham Pockley Alphageneron Pharmaceuticals
Source: apnews.com